BNIP3 and hepatocellular carcinoma: Therefore, avoiding HIFs stabilization and the subsequent prosurvival signaling, as well as BNIP3 expression reactivation, could be a promising therapeutic strategy to overcome sorafenib resistance in advanced HCC.